Sublime

Today, we announced a $200M round led by Addition, @a16z, @lightspeedvp, and Valor, with participation from existing investors @ThriveCapital, Altimeter, Trust Ventures, and @terraincap. Addition founder Lee Fixel will join our board alongside Antonio Gracias of Valor. https://t.co/TsdPzAwcLo

Royalty Pharma is a fascinating business. The name pretty much explains the business model -- they purchase royalty streams from academia, biotech, and pharma companies. It's, unsurprisingly, insane profitable. 63% EBIT margins and 127% operating cash flow... See more

https://t.co/gVJKI4ZVZ0

$NVO was once a market darling, now it gets a garbage treatment. Yet, revenue is exploding, margins are expanding and it has blockbuster drugs in the pipeline. Here is why $NVO is a 2x opportunity now: 🧵 https://t.co/nggZELQn80